BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9484827)

  • 21. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
    Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
    Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue expression of VEGF as a prognostic factor in early cervical squamous cell carcinoma.
    Terlikowski S; Lenczewski A; Sulkowska M; Famulski W; Sulkowski S; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():112-3. PubMed ID: 11820564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.
    Ambs S; Bennett WP; Merriam WG; Ogunfusika MO; Oser SM; Khan MA; Jones RT; Harris CC
    Br J Cancer; 1998 Jul; 78(2):233-9. PubMed ID: 9683299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
    Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
    J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
    Ming J; Zhang Q; Qiu X; Wang E
    Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.
    Smith BD; Smith GL; Carter D; Sasaki CT; Haffty BG
    J Clin Oncol; 2000 May; 18(10):2046-52. PubMed ID: 10811669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
    Volm M; Koomägi R; Mattern J
    Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expressions of vascular endothelial growth factor in cirrhotic tissues and their relations to proto-oncogene c-fos, c-myc.
    Shi BM; Wang XY; Mu QL; Wu TH; Yang Z; Zhang L; Li DP
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):388-91. PubMed ID: 14607712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
    Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
    Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
    Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
    Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of VEGF, EGFR, p16 in lip cancers and oral squamous cell carcinomas and their clinic significance].
    Yang W; Lin Z; Li L; Zhang G
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):99-101. PubMed ID: 12475418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas.
    Volm M; Koomägi R; Mattern J; Stammler G
    Br J Cancer; 1997; 75(12):1774-8. PubMed ID: 9192980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Kono T; Yazawa K; Igarashi J; Watanabe H; Nimura Y; Hanazaki K; Adachi W; Amano J
    Hepatogastroenterology; 1999; 46(26):952-8. PubMed ID: 10370645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
    Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis.
    Fujimoto K; Abe T; Müller NL; Terasaki H; Kato S; Sadohara J; Kono R; Edamitsu O; Ishitake T; Hayashi A; Rikimaru T; Hayabuchi N
    Radiology; 2003 Jun; 227(3):786-93. PubMed ID: 12714678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.